Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:CTRVP
FechaHoraFuenteTítuloSímboloCompañía
05/09/202405:36Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
05/09/202405:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
13/08/202414:57Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
15/07/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
15/07/202416:17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/07/202408:46Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/03/202415:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
06/03/202415:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/10/202316:22Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/10/202315:52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/07/202316:12Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
12/05/202315:19Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/04/202315:52Edgar (US Regulatory)Annual Report (10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/04/202305:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
21/11/202216:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/11/202216:21Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/11/202205:07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
26/07/202215:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
05/07/202207:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/02/202205:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
26/11/202105:09Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
19/11/202116:01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
20/05/202118:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
28/04/202116:14Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
24/02/202109:48Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
16/02/202116:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
12/02/202117:33Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
25/11/202015:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
18/11/202016:29Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
29/10/202015:07Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:CTRVP